Related Articles
Indirect comparison of the efficacy and safety of gefitinib and cetuximab‑based therapy in patients with advanced non‑small‑cell lung cancer
Comparative beneficiary effects of immunotherapy against chemotherapy in patients with advanced NSCLC: Meta-analysis and systematic review
Postoperative pathological complete response in a patient with PD‑L1‑negative stage IIIB lung squamous cell carcinoma following neoadjuvant tislelizumab treatment combined with chemotherapy: A case report and literature review
Consolidation chwemotherapy after concurrent chemoradiotherapy vs. chemoradiotherapy alone for locally advanced unresectable stage III non-small-cell lung cancer: A meta-analysis
Meta‑analysis of the efficacy and safety of sintilimab for treating advanced non‑small cell lung cancer